The latest closing stock price for Protagonist Therapeutics as of September 19, 2024 is 45.92.
An investor who bought $1,000 worth of Protagonist Therapeutics stock at the IPO in 2016 would have $2,925 today, roughly 3 times their original investment - a 18.64% compound annual growth rate over 8 years.
The all-time high Protagonist Therapeutics stock closing price was 49.69 on September 01, 2021.
The Protagonist Therapeutics 52-week high stock price is 48.00, which is 4.5% above the current share price.
The Protagonist Therapeutics 52-week low stock price is 13.72, which is 70.1% below the current share price.
The average Protagonist Therapeutics stock price for the last 52 weeks is 27.95.
An investor who bought $1,000 worth of Protagonist Therapeutics stock at the IPO in 2016 would have $2,925 today, roughly 3 times their original investment - a 18.64% compound annual growth rate over 8 years.
The all-time high Protagonist Therapeutics stock closing price was 49.69 on September 01, 2021.
The Protagonist Therapeutics 52-week high stock price is 48.00, which is 4.5% above the current share price.
The Protagonist Therapeutics 52-week low stock price is 13.72, which is 70.1% below the current share price.
The average Protagonist Therapeutics stock price for the last 52 weeks is 27.95.